David J. Hughes

Leverrier St, 
Bruce, ACT, AU 
Leverrier St, 
Bruce, ACT, AU 

Overview

David Hughes practices practicing medicine in Bruce, Australia.

His clinical expertise encompasses Cerebral Hypoxia, Burkitt Lymphoma, Parvovirus Antenatal Infection, and Mononucleosis.

He is actively involved in clinical research, co-authoring 74 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Leverrier St, Bruce, ACT, Australia
Other Locations
102-118 Murdoch Drive, Murdoch, WA 6150, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Pivotal Phase 1/2, Single-Arm, Open-label Study to Evaluate the Safety and Efficacy of Ponatinib With Chemotherapy in Pediatric Patients With Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Who Have Relapsed or Are Resistant or Intolerant to a Prior Tyrosine Kinase Inhibitor-Containing Therapy, or Who Have the T315I Mutation
A Pivotal Phase 1/2, Single-Arm, Open-label Study to Evaluate the Safety and Efficacy of Ponatinib With Chemotherapy in Pediatric Patients With Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Who Have Relapsed or Are Resistant or Intolerant to a Prior Tyrosine Kinase Inhibitor-Containing Therapy, or Who Have the T315I Mutation
Enrollment Status: Terminated
Publish Date: October 02, 2025
Intervention Type: Drug
Study Drug: Ponatinib
Study Phase: Phase 1/Phase 2

74 Total Publications

Antibody responses to inactivated (adjuvanted) and attenuated (non-adjuvanted) feline panleukopaenia virus vaccination, including in different injection sites.
Antibody responses to inactivated (adjuvanted) and attenuated (non-adjuvanted) feline panleukopaenia virus vaccination, including in different injection sites.
Journal: Journal of feline medicine and surgery
Published: May 05, 2026

Frequently Asked Questions about David J. Hughes

Is David J. Hughes a top-rated expert for Cerebral Hypoxia?

MediFind is an objective health platform that identifies experts based on real-world data. David J. Hughes is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does David J. Hughes participate in research or clinical trials?

Yes. David J. Hughes has published 74 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of David J. Hughes's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hughes's expertise for a condition
ConditionClose
        View All 14 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile